HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 1395 | 1677 | 83.2% | |
| HF 4 | 2011 | 1404 | 1680 | 83.6% | |
| HF 4 | 2012 | 1510 | 1780 | 84.8% | |
| HF 4 | 2013 | 1632 | 1879 | 86.9% | |
| HF004(S) | 2014 | 1090 | 1187 | 91.8% | |
| HF004(S) | 2015 | 1115 | 1218 | 91.5% | |
| HF004(S) | 2016 | 1300 | 1415 | 91.9% |
